Therapeutics · Hormones & Midlife Care

Menopause hormone therapy, reframed as a healthy-aging intervention

Science maps estrogen and progestogen receptors across 15 organs and links optimal hormone therapy to the most stable cognitive path.

Oct 4, 2026By longevitydocs™ editors
Science figure: estrogen and progestogen receptors across organs, changes across the female lifespan, and cognitive aging trajectories by menopause context
Figure: Science, October 2026

Science is treating menopause as an aging event, not a symptom list. The review maps estrogen and progestogen receptors across 15 organs, from brain and bone to vessel wall and gut, and argues that the drop in estradiol is a whole-body signal. Its strongest claim is on the brain: women on well-timed, appropriately dosed hormone therapy follow the most stable cognitive trajectory in the data it reviews.

Why it matters

When the flagship general-science journal frames hormone therapy as healthspan medicine, the conversation in your exam room changes. Expect the timing question (when to start, not whether) to dominate. Keep the evidence and the individual patient's risk profile in the same sentence when you discuss it.

Source: Menopause hormone therapy as a healthy-aging intervention. Science, women's health issue, October 2026.

Originally published in The Longevity Medicine Intelligence newsletter.

WRITTEN BYlongevitydocs™ editorsCurated by the longevitydocs™ editorial team from the weekly newsletter

Read more

All stories

Buzz in the chat

What physicians are debating inside the longevitydocs™ network.

All threads